|
Key takeaways • Most of what a cosmetic clinic sells can be advertised on Google. Consultations, cosmetic surgery, skin and laser treatments, and non-prescription aesthetic services all run without healthcare certification. • The rule that catches UK clinics is Restricted drug terms. For campaigns targeting anywhere other than Canada, New Zealand and the United States, prescription drug terms cannot appear in ads or landing pages at all. • Remarketing is not banned for healthcare advertisers. Predefined Google audiences are permitted; advertiser-curated ones such as Customer Match, your data segments and lookalikes are not. • Eligible (limited) is the normal running state for a compliant healthcare ad, not a fault to be fixed • In the UK, CAP rule 12.12 and the Human Medicines Regulations 2012 bite before Google’s policy does. A campaign can be Google-compliant and still be an ASA problem. • Most clinic disapprovals trace back to the landing page or the wider website, not to the ad text. |
Almost every guide to advertising a cosmetic clinic on Google is written as a list of prohibitions. That is the wrong way round, and it is why so many clinic owners believe the category is effectively closed to them. It is not.
A UK aesthetic clinic can advertise consultations, cosmetic surgery, laser and skin treatments, body contouring and most non-prescription services on Google Search today, with no certification, no special application and no legal exposure, provided the copy is honest and the landing page is clean.
The friction sits in a much narrower band than the industry folklore suggests: prescription injectables, weight-loss medicines, intimate procedures, regenerative claims, and the audience lists you use to retarget. Those five areas account for the overwhelming majority of clinic disapprovals we see.
This guide separates the two. It sets out the five Google policies that actually touch a cosmetic clinic account, gives a treatment-by-treatment verdict rather than a policy lecture, and then layers on the UK regulatory rules that most guidance on this subject ignores entirely because it was written for a US market where the injectables rules are close to inverted.
|
Who this is for It is general commercial guidance, not legal advice. Policy in this category changes several times a year. Check the linked Google policy pages before you launch. |
The Five Google Policies Cosmetic Clinics Must Check
Google does not have a cosmetic clinic policy. It has around thirty advertising policies, and a clinic account is touched by five of them at once.
A disapproval that feels arbitrary is usually the account tripping a policy the advertiser did not know applied. Knowing which five are in play turns a vague warning into a specific, fixable problem.
Healthcare and Medicines Policy
This is the umbrella. Google’s position is that ads and destinations for healthcare are expected to follow the relevant laws and industry standards, that some healthcare content cannot be advertised at all, and that other content can only be advertised in certain locations by advertisers who have applied and been approved.
Most of the sub-policies underneath it have nothing to do with an aesthetics clinic: online pharmacies, telemedicine prescribing, addiction services, clinical trial recruitment, opioids, health insurance. Three do matter.
– Restricted drug terms governs how you may refer to prescription medicines.
–Unapproved substances bars a list of products including anything containing hCG promoted for weight loss and anything implying it is as effective as a prescription drug.
–Speculative and experimental medical treatment bars promotion of unproven procedures and of cell and gene therapies.
One line in this policy is worth internalising: if your campaign targets allowed locations and your domain is properly certified where certification is needed, Google says the ad will be labelled Eligible (limited) and will run. Limited eligibility is the expected state, not a broken one.
Health in Personalized Advertising
Google treats health as a sensitive interest category, and the definition names cosmetic work directly. It covers invasive medical procedures including cosmetic surgery, surgical procedures and injections, and separately covers any health issue associated with intimate body parts or functions.
This policy does not restrict what you say. It restricts who you may target. If your ad or your landing page falls into the sensitive category, and most clinic pages do, you may use predefined Google audiences but you may not use advertiser-curated ones.
That single distinction is the source of nearly every wrong claim published about clinic remarketing, and it gets its own section below.
Restricted Drug Terms
Google restricts the use of prescription drug terms in three places: your ads, your landing pages and your keywords. What varies is where you are advertising, and the split is stark.
• Campaigns targeting Canada, New Zealand or the United States may use prescription drug terms for promotional purposes, in line with local law. Certification is not needed to use the terms in ads and landing pages, but it is needed to keyword-target them.
• Campaigns targeting anywhere else, including the United Kingdom, may not use prescription drug terms in ads or landing pages. Non-promotional use, such as regulatory warnings, legal notices, public health campaigns and academic material, is permitted.
Read that second bullet again if you are a UK clinic, because it is the reason so much American advice on this topic will get your account into trouble.
A US med spa can legitimately publish a page headed with a toxin brand name and bid around it. A UK clinic doing the same thing is outside Google policy before it has written a single ad, and outside UK law as well.
Sexual Content and Intimate Procedures
This policy is about depiction, not about the procedure. It splits into two tiers. Nudity, meaning exposed intimate body parts including representations that are blurred or censored, is strongly restricted and serves only against a narrow set of conditions including the user’s age, local law, their SafeSearch setting and their query.
Partial nudity is moderately restricted, and the threshold Google gives is specific: the lower or outer curve of the female breast exposed, or the majority of the buttocks exposed. Sexually suggestive poses and language sit in the same moderately restricted tier.
The serving consequences matter more than the labels. Ads carrying sexual content can run on the Google Search Network but cannot run on the Display Network, YouTube, AdMob or Google Ad Manager, and several asset types including image ads and video ads are closed to them.
For a breast surgery or body contouring clinic, that means a single clinical photograph in an asset group can silently remove your ads from three channels.
A separate, much narrower Sexual health and wellness policy exists, but it does not create a route for intimate cosmetic procedures.
It covers personal lubricants, permitted in a short list of countries including the UK, and prescription medicines for erectile dysfunction and female sexual interest or arousal disorder, permitted only in Canada, New Zealand and the United States and only for certified advertisers.
Misrepresentation and Unapproved Treatments
Misrepresentation is the policy most likely to catch ordinary, well-intentioned clinic marketing, because aesthetics sales language leans hard on the exact words it prohibits.
The sub-policies a clinic should know are:
– Unreliable claims, which bars claims that entice the user with an improbable result as the likely outcome even where that result is technically possible
– Unavailable offers, which bars promoting an offer that is not easily found on the destination
– Unclear relevance, which bars sending a click somewhere the ad did not promise
– Dishonest pricing practices, which requires the full cost to be disclosed clearly before and after purchase
– Clickbait, which explicitly bars using fear, guilt or other strong negative emotions to pressure a viewer into acting.
Above these sits Unacceptable business practices, which Google classes as egregious. Offering services you cannot deliver, including not holding the right licences or qualifications, and misrepresenting medical services in a way that risks a person’s health, both sit here.
Egregious violations lead to suspension on detection without prior warning. For a clinic, that is the difference between a bad week and the end of the account.
Alongside it, the healthcare policy bars promotion of speculative and experimental medical treatments outright, and bars promotion of cell and gene therapies except by holders of the relevant US FDA licence.
Content about cell or gene therapies that is exclusively educational or informational is allowed regardless of approval status, which is a narrow but genuinely useful opening for clinics that publish research explainers.
What Cosmetic Clinics Can Generally Advertise
Here is the list almost nobody publishes. None of the following requires healthcare certification, and none of it is prohibited content. All of it still sits inside the sensitive interest category, so the targeting rules apply, and all of it is still subject to Misrepresentation.
Clinic and Provider Consultations
The consultation is the safest asset a clinic owns, and it is not a compromise. It is what the ASA explicitly advises UK marketers to promote where a prescription-only medicine is involved: advertise the consultation service, not the product.
It is also the better commercial unit. A consultation booking is a qualified lead attached to a clinician’s diary, while a treatment-page click is a browse.
Practically: consultation-led ads clear policy review more cleanly, they let you talk about the practitioner’s credentials rather than a medicine, and they give you a landing page that can stay free of restricted terms while your deeper educational content sits elsewhere on the site.
Cosmetic Surgery Services
Rhinoplasty, breast augmentation and reduction, abdominoplasty, liposuction, blepharoplasty, facelift and gynaecomastia surgery are all advertisable on Google. Surgery is not prohibited content. It is named in the personalized advertising policy as an invasive medical procedure, which is a targeting constraint, not a content ban.
The realistic risk for a surgical practice is imagery, not text. Clinical photography of the torso is where the sexual content thresholds start to matter, and asset-level restrictions can quietly limit where a Performance Max or Display campaign serves without generating an obvious disapproval notice.
Review your image assets against the partial nudity threshold before you review your headlines.
Skin and Laser Treatments
Laser hair removal, IPL, laser resurfacing, microneedling, radiofrequency microneedling, chemical peels, mesotherapy and medical facials are the lowest-friction category in aesthetics.
The equipment is regulated as a medical device rather than a medicine, so Restricted drug terms does not apply, and the treatments are not on any prohibited list.
Two cautions. First, resurfacing and peel results attract outcome language, and outcome language attracts Unreliable claims. Second, if the same landing page also lists your injectables menu by product name, the page is what gets reviewed, and a compliant laser ad will be disapproved for a term that appears three scrolls further down.
Non-Prescription Aesthetic Services
Cryolipolysis, HIFU, radiofrequency skin tightening, LED phototherapy, lymphatic massage, cosmeceutical skincare retail and most wellness add-ons run without restriction.
The one trap is claim inflation. Under UK rules a cosmetic product presented as able to treat or prevent a condition, or to correct or modify a physiological function, becomes medicinal by presentation, and a marketer needs the relevant licence to make those claims.
A serum described as hydrating is a cosmetic. The same serum described as treating rosacea is a medicine you are not licensed to advertise.
Treatments and Promotions That Need Extra Review
These five categories carry a real chance of disapproval or of an ASA complaint. None of them is automatically unadvertisable, but each needs a deliberate decision about copy, destination and targeting before launch rather than after the first rejection.
Botox, Dysport and Other Prescription Injectables
This is the single most misunderstood area in UK clinic marketing, and two separate rulebooks converge on it.
Google’s rule, Botulinum toxin products are prescription medicines, so their names are prescription drug terms. Because a UK campaign targets a location outside Canada, New Zealand and the United States, those terms may not appear in your ads or your landing pages. Not in a headline, not in a description, not in the body copy of the page the ad points to.
The UK rule, which is stricter and is law. CAP Code rule 12.12 prohibits advertising prescription-only medicines or prescription-only medical treatments to the public, and it is an offence under the Human Medicines Regulations 2012 to promote the prescription, supply, sale or use of a prescription-only product.
Botulinum toxin under any brand name is a prescription-only medicine in the UK, and so is hyaluronidase, the enzyme used to dissolve filler. The ASA treats almost any reference, direct or indirect, as a breach, and this applies to your own website and social posts, not only to paid placements.
The ASA has also closed the obvious workaround. Euphemisms that clearly point at the same medicine, including anti-wrinkle framing in context, have been ruled against as indirect promotion.
Where a clinic offers a toxin alongside other injectables, CAP guidance permits advertising the treatments collectively as cosmetic fillers or injected fillers, but does not permit naming the toxin or describing it in a way that implies it is on offer.
|
The workable position – Keep every named toxin brand and the generic term off any page an ad points to. – If you publish genuinely educational, non-promotional information about the medicine, keep it on a separate page that no ad destination reaches. – Do not bid on toxin brand keywords in a UK campaign. |
Dermal Fillers and Injectable Treatments
Fillers sit in a materially different position from toxins, and almost no guidance separates them. Hyaluronic acid dermal fillers are regulated in the UK as medical devices, not as prescription-only medicines.
Restricted drug terms does not apply to them, and CAP rule 12.12 does not apply to them. You may name filler treatments in ads and on landing pages.
What still applies is everything else. Injections are named in the personalized advertising policy, so the audience restrictions bite. Longevity and outcome claims fall under Unreliable claims, and “results that last two years” is exactly the shape of claim Google’s policy describes as enticing with an improbable result.
Package pricing must disclose the full cost. And if the same page cross-sells a toxin by name, the page is non-compliant regardless of how careful the filler copy is.
Weight-Loss and Prescription Programmes
Medical weight management has become a major aesthetics revenue line and it carries the heaviest policy load in this list.
GLP-1 receptor agonist brand names are prescription drug terms and follow the same location rule as toxins: not usable in ads or landing pages for a UK campaign. Separately, the Unapproved substances policy names products containing hCG in relation to weight loss or weight control, and bars products that imply they are as effective as prescription drugs, which rules out most of the supplement adjacent copy in this space.
If your clinic actually prescribes and dispenses remotely, you have moved into Prescription drug services territory, which requires certification, and in the UK the telemedicine route runs through LegitScript accreditation.
A compliant UK weight-management campaign therefore advertises a medically supervised weight-management consultation, describes the clinical assessment, names no medicine, and makes no numerical promise about loss.
Intimate-Area Cosmetic Treatments
Labiaplasty, vaginal rejuvenation, intimate laser and intimate lightening trigger two policies simultaneously. The personalized advertising policy names health issues associated with intimate body parts or functions as sensitive, and the sexual content policy governs how the treatment may be depicted and described.
These can be advertised, and clinics do advertise them on Search, but the margin is thin. Use clinical terminology throughout. Avoid any framing around pleasure, enhancement or desirability, which moves the ad into sexually suggestive themes.
Use no anatomical imagery at all. Expect Search-only serving, because sexual-content-restricted ads cannot run on Display, YouTube or Ad Manager, and plan the media mix accordingly rather than discovering it in a performance report.
Regenerative, Stem-Cell and Experimental Treatments
This is the clearest no in the whole category, and the one clinics most often walk into believing they are on the right side of it. Google does not allow promotion of speculative or experimental medical treatments, and does not allow promotion of cell or gene therapies at all outside a narrow US exception for holders of the relevant FDA licence.
In practice that reaches stem-cell facelifts, exosome therapy marketed for regeneration, and any platelet or biologic treatment sold on a claim that outruns its evidence. It also reaches the account, not just the ad: applications for healthcare certification are routinely rejected where the website carries speculative treatment claims elsewhere.
The permitted route is genuinely narrow, and it is educational content about cell and gene therapies presented as information rather than as an offer.
What Cosmetic Clinics Should Not Run
A short, unambiguous list. Each of these has cost a UK clinic either a disapproval, an ASA ruling or an account.
Any named prescription-only medicine in an ad or on a landing page a UK ad points to, including toxin brand names, the generic term, hyaluronidase and GLP-1 brands.
• Guaranteed, permanent or risk-free outcome language, in any asset, including sitelinks and callouts.
• Before and after imagery presented as the typical result, or used in a way that implies an outcome the average patient will not get.
• Countdown timers, artificial scarcity, or copy that leans on shame, ageing anxiety or body dissatisfaction to force a click. Google’s clickbait policy names inducing strong negative emotions specifically.
• Comparative claims that a non-prescription treatment works as well as a prescription one.
• Competitions, prize draws or loyalty rewards featuring a prescription-only treatment, which the ASA treats as promotion of the medicine.
• Anything targeted at, or reasonably likely to reach, under-18s. Users under 18 are not eligible for personalized advertising of any kind, and in England botulinum toxin and filler procedures for cosmetic purposes may not be provided to under-18s.
• Claims of accreditation, registration or specialist status the practice does not hold. This is an egregious violation and carries suspension without warning.
• Ads pointing at a homepage or menu page that names restricted terms, however clean the ad itself is.
Search, Display, YouTube or Performance Max?
Campaign type is usually treated as a budget question. In a restricted category it is a policy question first, because the serving rules differ by network and because a single flagged asset has different consequences in each.
Google Search
Search should carry the majority of a clinic’s spend, and not only for the obvious intent reasons. It is the most permissive network in this category: ads carrying restricted sexual content can still run on the Google Search Network when they cannot run anywhere else.
Text-only assets are also the easiest to diagnose. When a Search ad is disapproved you can see exactly which headline or which destination caused it.
Structure by treatment rather than by budget. A single campaign mixing laser, surgery and injectables gives every ad group the risk profile of the riskiest treatment in it, and one disapproval can strand the whole group’s budget.
Display Network
Display is where the personalized advertising restrictions hurt most, because Display is where advertiser-curated audiences normally earn their keep. Without Customer Match or your data segments, you are left with predefined audiences, contextual placements and managed placements, which is a workable but blunter instrument.
Display also cannot serve ads carrying sexual content at all, and image assets are the most common trigger for that classification in aesthetics. Treat Display as a supporting awareness channel with conservative creative, not as a retargeting engine.
YouTube
YouTube is genuinely strong for cosmetic surgery, where the decision is long, considered and driven by trust in an individual surgeon. Consultation walkthroughs, recovery explainers and practitioner introductions perform well and sit comfortably inside policy.
The constraint is absolute rather than graded: ads classed as sexual content cannot run on YouTube. For a body or breast practice this rules out most clinical footage. Build the creative around the clinician and the consultation experience instead, and keep the surgical detail on the site.
Performance Max
Performance Max is permitted for cosmetic clinics, and it is the campaign type we most often advise clinics to postpone rather than avoid.
The reason is diagnostic, not prohibitive. Performance Max bundles Search, Display, YouTube, Discover, Gmail and Maps into one campaign, so it inherits every network’s restrictions at once while giving you the least visibility into which one is limiting you.
Audience signals cannot draw on advertiser-curated data in a sensitive category, which removes much of the mechanism people buy Performance Max for. And because assets are recombined automatically, a compliant headline can be paired with an image that shifts the whole asset group into restricted serving.
The sequence that works: establish clean, converting Search campaigns first, verify that every asset and every destination clears review on its own, then extend into Performance Max with a tightly controlled asset group, brand exclusions and final URL expansion switched off.
Can Cosmetic Clinics Use Remarketing?
Yes, within limits, and the widely repeated claim that remarketing is forbidden for healthcare advertisers is simply wrong. Google’s own policy sets out both a permitted and a prohibited column. The distinction is not between remarketing and no remarketing. It is between audiences Google builds and audiences you build.
Predefined Google Audiences
These are permitted even when you are promoting in a sensitive interest category, because Google strips the sensitive signals out of them before they reach you. The permitted list covers in-market segments, affinity segments, demographics and detailed demographics (with named exceptions that do not affect UK healthcare), life events, location targeting and custom segments.
One caveat is easy to miss and worth quoting to your account manager. Custom segments that use sensitive creative assets, or that point to a sensitive landing page, will serve only on Display campaigns and only to non-sensitive audiences or contextually.
In every other campaign type, a custom segment attached to a sensitive asset or destination will not be eligible to serve at all. For a clinic, that means a custom segment can look correctly configured and silently deliver nothing.
Advertiser-Curated Audiences
These are not permitted, because they may carry sensitive user signals you have gathered. The prohibited list is specific: Customer Match, your data segments, audience expansion and lookalike segments.
Read plainly, that closes the four things clinics most want to do. You may not upload a patient email list. You may not build a segment of people who viewed the rhinoplasty page and chase them. You may not build a lookalike from your best-converting patients.
You may not switch on audience expansion in a campaign whose landing pages are clinical. Separately, users under 18 are not eligible for personalized advertising of any kind, and advertisers using advertiser-curated audiences may not upload customer information gathered from viewers of child-directed content.
Safer Alternatives
The workarounds are less clever than the thing they replace, and they are effective.
• In-market and life-event segments. Predefined, permitted, and in aesthetics the life-event signals around weddings and milestone birthdays are unusually well matched to demand.
• Contextual and managed placements on Display and YouTube. You are targeting the content rather than the person, which sidesteps the policy entirely.
• Tight geography and ad scheduling. A 10 to 15 mile radius around the clinic, weighted to hours when someone answers the phone, recovers more of the lost efficiency than most clinics expect.
• Brand defence on Search. The people your remarketing would have chased overwhelmingly come back through a branded search. Owning that query is remarketing by another route.
• First-party data used offline. Your CRM list is still yours. Use it for email, recall and reactivation. What you may not do is upload it to Google as a targeting segment.
Compliant Ad Copy Examples
The pattern in every rewrite below is the same: move the promise from the outcome to the process, and from the medicine to the practitioner. Compliant copy is not vaguer copy. It is more specific about things you can substantiate.
Injectables. Do not run: “Botox From £149. Wrinkles Gone In 3 Days.” This names a prescription-only medicine, promises an outcome and puts a timeframe on it. Run instead: “Consultant-Led Aesthetics Clinic. Book A Face-to-Face Consultation.” The medicine has gone, the promise has gone, and the differentiator is now something you can prove.
Cosmetic surgery. Do not run: “Best Rhinoplasty In Manchester. Guaranteed Natural Results.” A superlative you cannot substantiate plus a guarantee. Run instead: “Rhinoplasty In Manchester. GMC-Registered Plastic Surgeons. Consultation From £150.” Verifiable credential, real location, disclosed price.
Weight management. Do not run: “Lose 2 Stone By Summer. Weight Loss Injections Available.” A quantified promise plus a prescription medicine reference. Run instead: “Medically Supervised Weight Management. Clinical Assessment With A Prescriber.” Describes the service, not the drug or the result.
Laser and skin. Do not run: “Permanent Hair Removal. 100% Results Or Money Back.” Permanence is a claim the technology does not support and the refund promise creates a pricing obligation. Run instead: “Laser Hair Removal In Leeds. Course Plans From £X. Free Patch Test.” Honest, priced, and it pre-qualifies the click.
Intimate treatments. Do not run anything framed around confidence in the bedroom or intimate wellness in a suggestive register. Run instead: “Labiaplasty Consultation. Female Consultant Surgeon. Private, Clinical Setting.” Clinical throughout, and it answers the question the patient is actually asking.
|
A quick test before you publish Could a regulator ask you to substantiate this claim, and could you? Does the ad name a medicine, or a service? Does the landing page deliver exactly what the headline promised, above the fold? Would you be comfortable if this ad were read aloud at an ASA hearing? |
Cosmetic Clinic Landing-Page Checklist
Most clinic disapprovals are destination problems wearing an ad’s clothing. Google reviews the page, and often the wider site, not just the text you wrote in the interface. Work through this before you point a single ad at a URL.
• No restricted terms anywhere on the page, including in navigation, footer menus, treatment menus, blog teasers, testimonials, image alt text and schema markup. This is where clinics almost always get caught.
• The page delivers the ad’s promise above the fold. Unclear relevance and unavailable offers are both destination-side disapprovals.
• Full pricing disclosed, including consultation fees, whether the consultation fee is redeemable, and what a quoted “from” price actually includes.
• Business identity is unmissable. Registered name, physical clinic address, a working local phone number, and regulator registration details. Transparency about who you are is a live requirement under Misrepresentation, and thin identity information is a common trigger.
• Named practitioners with real credentials, linked to the relevant register where possible. This satisfies Google’s qualification requirements and it converts.
• Risks, recovery and suitability stated honestly. A page that only sells is a Misrepresentation risk. A page that explains who is not a candidate reads as clinical and pre-qualifies leads.
• HTTPS, fast on mobile, no interstitials that block content. Destination experience disapprovals cover pages that are unnecessarily difficult or frustrating to navigate.
• Crawlable by Google AdsBot, returning a 200 in every location you target. Destination not working and destination not crawlable are among the most common and most invisible causes of a stalled campaign.
• A privacy policy that covers how enquiry data is handled, which matters for both policy review and UK GDPR.
• Before and after galleries, if used, behind consent and framed as individual results, never as the typical outcome, and reviewed against the partial nudity thresholds if any body imagery is included.
Does Your Clinic Need Google Certification?
In almost all cases, no. This is worth stating plainly because a small industry has grown up selling clinics a certification they do not need.
Google’s healthcare certifications exist for specific business models: prescription drug services, online pharmacies, telemedicine providers, pharmaceutical manufacturers, addiction services and health insurance.
A cosmetic clinic that consults, treats and operates in person fits none of them. You do not need certification to advertise a consultation, cosmetic surgery, laser treatment or a non-prescription aesthetic service.
Certification becomes relevant when the model changes. If you prescribe remotely, dispense, or run a telemedicine arm, you are in prescription drug services territory.
In the UK that route runs through the General Pharmaceutical Council for pharmacies and through LegitScript accreditation for telemedicine providers, before you apply to Google at all.
If you do need to apply, four details determine whether it succeeds:
1.Apply for the right category. Google’s guidance is explicit that you should not apply for a category that does not match your business model. A mismatched application is a rejection.
2. Apply at the child account level, not at the manager account level. This is the single most common procedural failure.
3. Include your Google Ads customer ID and the exact domain you want certified, and make sure the site is fully functional and globally accessible when the reviewer looks at it.
4. If an agency is applying on your behalf, supply documentation of the relationship on clinic letterhead. Where a professional register is involved, the link you provide must resolve directly to the practitioner’s profile, because Google will not search a register for a name.
Where an application is refused, the reason is frequently a term or claim elsewhere on the website rather than anything in the application itself. Audit the whole site before you reapply.
Why Cosmetic Clinic Ads Get Disapproved
Google names the policy in the disapproval notice, and the named policy tells you exactly where to look. These are the six that account for nearly all clinic rejections, and the fix for each.
Restricted Drug Terms
What it means. A prescription drug term has been found in your ad, your landing page or your keyword list, and your campaign targets a location where promotional use is not permitted.
The fix. Search the full landing page source, not just the visible copy, for every toxin brand name, the generic term, hyaluronidase and any GLP-1 brand. Check navigation labels, alt text and structured data.
Remove the terms or repoint the ad to a clean destination. Do not appeal until the page is genuinely clear, because a failed appeal on an unchanged page adds a violation to the account record.
Personalized Advertising
What it means. Your ad or destination falls into the sensitive health category and an advertiser-curated audience is attached somewhere in the targeting.
The fix. Google gives three routes. Remove the advertiser-curated audiences from the campaign, ad group and asset group settings, remembering that inherited targeting is easy to miss.
Or edit the site or ad content so it no longer falls within the policy, which for a clinic is rarely realistic. Or appeal if you believe the classification is wrong. In practice the first route is the answer nine times out of ten.
Healthcare and Medicines
What it means. Something in the account is in scope of the umbrella healthcare policy: a speculative treatment claim, an unapproved substance, or a business type that needs certification you do not hold.
The fix. Identify which sub-policy was cited. If it is speculative or experimental treatment, the claim has to go from the site, not just from the ad.
If it is a certification requirement, confirm you actually fall inside that business model before applying, and confirm you are targeting only locations where the activity is permitted.
Sexual Content
What it means. An image, a video frame or a phrase has been classified as nudity, partial nudity or sexually suggestive. For clinics this is usually a clinical photograph or an intimate-treatment page, and it frequently arrives as restricted serving rather than a hard disapproval.
The fix. Audit image and video assets against the stated thresholds: the lower or outer curve of the breast, the majority of the buttocks. Replace clinical body imagery with clinic environment, practitioner or lifestyle imagery.
Move the language on intimate treatments into clinical register. Expect the ad to remain Search-only, and note that this policy carries a warning at least seven days before any suspension, so it is recoverable if you act.
Misrepresentation
What it means. A claim, a price or an offer does not hold up. Most often it is Unreliable claims triggered by outcome language, or Unavailable offers triggered by a promotion the landing page does not carry.
The fix. Strip guarantees, superlatives, permanence and timeframes. Make sure any advertised offer is visible on the destination without hunting. Disclose the full price.
If the disapproval cites Unacceptable business practices rather than a lesser sub-policy, treat it as urgent: that tier can suspend an account without warning.
Destination Not Working or Insufficient Transparency
What it means. Google’s crawler could not reach or use your page properly, or the site does not make clear enough who is behind it. Destination requirements covers pages that return an error to AdsBot, pages not crawlable, pages not accessible from the targeted location, pages that are difficult or frustrating to navigate, and pages with insufficient original content. Transparency about business identity is enforced under the Misrepresentation policies.
The fix. Test the exact final URL, including tracking parameters, on mobile and desktop. Confirm the domain in the display URL matches the final URL and that no redirect crosses domains.
Confirm AdsBot is not blocked in robots.txt, a genuinely common cause on clinic sites built by agencies that blocked crawlers on staging and never unblocked them. Then make the identity information unmissable: registered business name, clinic address, working local phone number with active voicemail, and regulator registration.
Pre-Launch Compliance Checklist
Run this before any new clinic campaign goes live, and again whenever the treatment menu changes. It takes under an hour and it is cheaper than an appeal.
1. Confirm which of the five policies apply to each treatment you plan to advertise, and separate treatments into their own campaigns accordingly.
2. Search every intended landing page, and the site-wide navigation and footer, for prescription drug terms. Include alt text, schema and menu labels.
3. Check every headline, description, sitelink, callout and structured snippet for guarantees, superlatives, permanence and timeframes.
4. Review every image and video asset against the partial nudity thresholds, and against how it will look recombined by automation.
5. Open the campaign, ad group and asset group targeting and confirm no Customer Match list, data segment, lookalike or audience expansion setting is attached.
6. Confirm any custom segment is not pointing at a sensitive landing page in a non-Display campaign, where it will not serve.
7. Test each final URL live: 200 status, HTTPS, fast on mobile, AdsBot not blocked, display URL domain matching.
8. Verify pricing on the page matches pricing in the ad, and that any promotion is visible without scrolling for it.
9. Verify business identity on the destination: registered name, address, local phone with voicemail, regulator registration, privacy policy.
10. Apply a UK regulatory pass separately from the Google pass: CAP rule 12.12, MHRA position on prescription-only medicines, and the relevant professional body’s advertising standards.
11.Set a weekly recurring review of the policy status of every ad and asset, and diarise a quarterly re-read of the Google policy pages, which change several times a year.
If an ad comes back Eligible (limited) after all this, that is the system working. It means the ad is compliant and is serving inside the constraints of a restricted category. It is not a problem to be escalated.
Frequently asked questions
Can cosmetic clinics advertise on Google?
Yes. Cosmetic clinics can advertise consultations, cosmetic surgery, laser and skin treatments and most non-prescription aesthetic services on Google Ads without healthcare certification. The category is restricted rather than prohibited, which means ads are reviewed more closely and typically run with an Eligible (limited) status, not that clinics are shut out.
Can clinics advertise Botox on Google Ads?
Not in the UK. Botulinum toxin products are prescription-only medicines, and Google’s Restricted drug terms policy bars prescription drug terms from ads and landing pages for campaigns targeting anywhere other than Canada, New Zealand and the United States. UK law goes further: CAP Code rule 12.12 prohibits advertising prescription-only medicines to the public, and promoting a prescription-only product is an offence under the Human Medicines Regulations 2012. Advertise the consultation instead.
Can a clinic bid on Botox as a keyword?
Not in a UK campaign. Google restricts prescription drug terms in keywords as well as in ads and landing pages. In Canada, New Zealand and the United States, keyword-targeting prescription drug terms is possible but requires certification even though using the terms in ads and landing pages does not. UK clinics should build keyword sets around consultations, clinic and practitioner searches, and non-restricted treatment terms.
Are dermal filler ads allowed?
Yes. Hyaluronic acid dermal fillers are regulated as medical devices rather than prescription-only medicines, so neither Google’s Restricted drug terms policy nor CAP rule 12.12 applies to naming them. Filler ads still sit in the sensitive health category for targeting purposes, and longevity or outcome claims still fall under Google’s Unreliable claims policy. Note that hyaluronidase, used to dissolve filler, is a prescription-only medicine and cannot be named.
Can cosmetic surgeons use remarketing?
Partly. Google’s Health in personalized advertising policy permits predefined Google audiences, including in-market segments, affinity segments, life events, demographics and custom segments, even when promoting in a sensitive category. It prohibits advertiser-curated audiences, which means no Customer Match, no data segments built from site visitors, no lookalike segments and no audience expansion. The common claim that healthcare remarketing is banned outright is incorrect.
Can before-and-after images appear in Google Ads?
There is no blanket ban, but three constraints apply. Images must not imply an outcome that is not typical, which engages the Unreliable claims policy. Body imagery must stay within the sexual content thresholds, since exposure of the lower or outer curve of the breast or the majority of the buttocks moves the ad into restricted serving. And in the UK, before-and-after imagery must not amount to indirect promotion of a prescription-only medicine. Many clinics find results galleries work better on the website than in ad assets.
Can breast-augmentation clinics advertise on Google?
Yes. Breast augmentation is not prohibited content. It is named in the personalized advertising policy as an invasive medical procedure, so advertiser-curated audiences are unavailable, and the real practical constraint is imagery. Clinical photography that crosses the partial nudity threshold will restrict where the ad can serve, removing it from Display, YouTube and Ad Manager while leaving it eligible on Google Search.
Are laser hair-removal ads allowed?
Yes, and this is one of the lowest-risk categories in aesthetics. Laser and IPL devices are regulated as medical devices, not medicines, so no drug-term restriction applies. The two things to watch are permanence claims, since Unreliable claims covers results that are possible but not the likely outcome, and shared landing pages: a compliant laser ad pointing at a treatment menu that names a prescription injectable will still be disapproved.
Does every cosmetic clinic need healthcare certification?
No. Google’s healthcare certifications exist for online pharmacies, telemedicine and prescription drug services, pharmaceutical manufacturers, addiction services and health insurance. An in-person cosmetic clinic fits none of these and does not need certification to advertise consultations, surgery or aesthetic treatments. Certification becomes relevant only if the clinic prescribes or dispenses remotely, which in the UK requires GPhC registration or LegitScript accreditation before applying to Google.
Why does an ad say “Eligible (limited)”?
Because it is a compliant healthcare ad. Google’s own healthcare policy states that where a campaign targets allowed locations and the domain is certified where certification is required, the ad will be labelled Eligible (limited) and can run in allowed locations. For clinics this is the normal steady state rather than a fault. It means the ad is serving with the restrictions of a sensitive category applied, and there is usually nothing to fix.
Can Performance Max be used for cosmetic procedures?
Yes, but it is rarely the right starting point. Performance Max spans Search, Display, YouTube, Discover, Gmail and Maps, so it inherits every network’s restrictions simultaneously while giving the least visibility into which is limiting delivery. Audience signals cannot use advertiser-curated data in a sensitive category, and automatic asset recombination can push an asset group into restricted serving. Establish clean Search campaigns first, verify every asset and destination independently, then extend into Performance Max with tight asset control and final URL expansion off.
What should a clinic do after a policy disapproval?
Read the named policy in the notice, because it tells you where the problem is. Fix the underlying cause, which is more often the landing page or the wider site than the ad text, then resubmit. Only appeal once the issue is genuinely resolved or you are confident the classification is wrong, since failed appeals accumulate on the account record. Distinguish a disapproval, which affects one ad, from an account suspension, which stops everything. Egregious violations such as unacceptable business practices can suspend an account without warning, while sexual content and destination violations carry at least seven days’ notice.
References
• Google Ads, Healthcare and medicines policy – https://support.google.com/adspolicy/answer/176031
• Google Ads, Restricted drug terms – https://support.google.com/adspolicy/answer/15595717
• Google Ads, Health in personalized advertising – https://support.google.com/adspolicy/answer/16701855
• Google Ads, Sexual content – https://support.google.com/adspolicy/answer/6023699
• Google Ads, Sexual health and wellness – https://support.google.com/adspolicy/answer/15275138
• Google Ads, Misrepresentation – https://support.google.com/adspolicy/answer/6020955
• Google Ads, Destination requirements – https://support.google.com/adspolicy/answer/6368661
• ASA and CAP, Botox and non-surgical cosmetic interventions – https://www.asa.org.uk/advice-and-resources/cap-bitesize/rules-for-advertising-botox.html
• ASA and CAP, Prescription for compliance: POMs and the Code – https://www.asa.org.uk/news/prescription-for-compliance-poms-and-the-code.html
• ASA and CAP, Healthcare: prescription-only medicines (websites) – https://www.asa.org.uk/advice-online/health-prescription-only-medicines-websites.html
